Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,726 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

NCT05186805

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Thousand Oaks, California, United States
  • Dermavant Investigative Site Centennial, Colorado, United States
  • Dermavant Investigative Site Coral Gables, Florida, United States
  • Dermavant Investigative Site Hialeah, Florida, United States
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

NCT05014568

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Phoenix, Arizona, United States
  • Dermavant Investigative Site Bryant, Arkansas, United States
  • Dermavant Investigative Site Beverly Hills, California, United States
View all 67 locations
View Trial Details
Completed

A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma

NCT06644924

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Encinitas, California, United States
  • Research Site Lancaster, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

NCT05032859

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Fort Smith, Arkansas, United States
View all 62 locations
View Trial Details
Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

NCT04130191

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Klinikum der Johann-Wolfgang Goethe-Universitat Frankfurt am Main, Hesse, Germany
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universitatsklinikum Dusseldorf Düsseldorf, Germany
View all 19 locations
View Trial Details
Completed

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

NCT06631170

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The Second affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Aerospace General Hospital Beijing, Beijing Municipality, China
  • Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
View all 61 locations
View Trial Details

Related conditions